Advertisement
Obstetrics/Gynecology
Subscribe to Obstetrics/Gynecology
View Sample

FREE Email Newsletter

Two Additional Private Payers Provide Coverage for Posterior Tibial Nerve Stimulation Delivered Using the Uroplasty Urgent® PC Neuromodulation System

July 18, 2011 4:41 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, July 18, 2011 /- Uroplasty, Inc. (NASDAQ: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that two additional private insurance payers will cover  posterior tibial...

Spirus Medical acquired by Tokyo firm

July 6, 2011 5:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Spirus Medical Inc., a West Bridgewater maker of endoscope insertion devices, has been sold to Tokyo-based Olympus Corp.

Hologic to Release Third Quarter Fiscal 2011 Operating Results on Monday, August 1, 2011

June 28, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., June 28, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced plans to...

Advertisement

Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA

June 27, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

LIVINGSTON, N.J. and MORRISTOWN, N.J., June 27, 2011 /- Columbia Laboratories, Inc. (Nasdaq: CBRX ) and Watson Pharmaceuticals, Inc. (NYSE: WPI ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Columbia's New Drug Application (NDA) for PROCHIEVE...

Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit

June 23, 2011 4:41 am | by Bio-Medicine.Org | News | Comments

BIRMINGHAM, Ala. June 23, 2011 /- Centrix Pharmaceutical, Inc., a privately-held specialty pharmaceutical company focused on Pediatrics and Women's Health, announces a promotional agreement with CutisPharma, Inc., a Woburn, Massachusetts based company. The partnership will include the...

Transgenomic, Inc. Launches Best-in-Class Next-Generation Sequencing Test for Nuclear Mitochondrial Disorders at the 2011 United Mitochondrial Disease Foundation Meeting

June 16, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

OMAHA, Neb., June 16, 2011 /- Transgenomic, Inc. (OTC/BB: TBIO) today announced the launch of the Nuclear Mitome Test, a genetic test to aid physicians in the diagnosis of mitochondrial disorders. The Nuclear Mitome Test, employs next-generation sequencing technology to identify mutations...

Theramed Corporation to Launch Glenveigh Products, ebbâ„¢ and jettyâ„¢ at the Society of Obstetricians and Gynecologists of Canada

June 14, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, June 14, 2011 /- Theramed Corporation ("Theramed") announces that it will launch ebb™ and jetty™ at the 67th Clinical Meeting of the Society of Obstetricians and Gynecologists of Canada. The two newly developed medical devices are to be used to advance...

Thomson Reuters - NPR Health Poll Finds Three-Quarters of Americans Support Government Insurance Subsidies for Birth Control Pills

June 10, 2011 2:31 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich. and WASHINGTON, June 10, 2011 /- American consumers are broadly in favor of oral contraceptive coverage by both private and government-subsidized health insurance plans, according to the Thomson Reuters-NPR Health Poll. (Logo:...

Advertisement

Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018

May 31, 2011 1:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 31, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018...

OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment

May 24, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J. and AUSTIN, Texas, May 24, 2011 /- A paper published in the June issue of Obstetrics & Gynecology demonstrated that adding OVA1 to a physician's preoperative assessment of a woman's ovarian mass would identify more ovarian cancers than a physician's preoperative...

Florida Legislature Refuses to Limit Mercury in Vaccines

May 9, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., May 9, 2011 /PRNewswire-USNewswire/ – CoMeD – On Friday, May 6, 2011, in Tallahassee, Florida, a Republican State Senator filed an amendment to regulate vaccines containing mercury in Florida.  The amendment would have made it illegal to buy, sell,...

May is Older Americans Month

May 3, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

WILMINGTON, N.C., May 3, 2011 /- Former president John F. Kennedy designated the month of May as Older Americans Month in 1963 and it has since become a long-standing tradition to pay tribute to older adults. At that time, only 17 million Americans had reached their 65th birthday,...

Making Childbirth Safer

April 27, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

ATLANTA, April 27, 2011 /- Trig Medical, Inc. announces the U.S. launch of LaborPro®, the new standard for labor progression management, at the American Congress of Obstetricians and Gynecologists (ACOG) 2011 Annual Clinical Meeting, taking place April 30 – May 4, 2011 in...

Advertisement

Ferring Celebrates Winners of 2010 My Little Miracle Essay Contest During National Infertility Awareness Week

April 25, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., April 25, 2011 /- Celebrating National Infertility Awareness Week, April 24-30, 2011, Ferring Pharmaceuticals Inc. is honoring three lucky families who won its 2010 My Little Miracle Essay Contest for their inspirational stories about overcoming their struggle with...

Clinical Studies Results of Uroplasty Products Scheduled for Presentation at Three Professional Meetings

April 25, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

MINNETONKA, Minn., April 25, 2011 /- Uroplasty, Inc. (NASDAQ: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent® PC...

Smith & Nephew Endoscopy unit marks medical device milestone

April 6, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The Andover-based Endoscopy division of Smith & Nephew plc, a medical devices firm with headquarters in London, has had its flagship product, the TRUCLEAR System, hit 30,000 procedures.

Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results

April 6, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

LIVINGSTON, N.J. and MORRISTOWN, N.J., April 6, 2011 /- Columbia Laboratories, Inc. (Nasdaq: CBRX ), and Watson Pharmaceuticals, Inc. (NYSE: WPI ), today announced the publication of Phase III PROCHIEVE® (progesterone gel) data in today's online version of Ultrasound in Obstetrics...

IBM Helps Bring Smarter Healthcare to Nigeria's Cross River State

April 6, 2011 2:34 am | by IBM | News | Comments

Ahead of World Health Day, IBM (NYSE: IBM) announced details of its involvement with two government programs in Cross River State, Nigeria aimed at providing access to free healthcare and alleviating poverty. E-mail this page Save to del.icio.us Digg this

Eisenhower Medical Center Reports Theft of Computer and Television

March 30, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

RANCHO MIRAGE, Calif., March 30, 2011 /- Eisenhower Medical Center (EMC) has implemented additional security procedures and protocols to help ensure patient privacy and security after a hospital computer and a television were stolen in a burglary on Friday, March 11. The computer was...

TV Personality Vanessa Minnillo Teams Up With Bayer and March of Dimes to Launch National Folate Awareness Campaign

March 15, 2011 7:37 am | by Bio-Medicine.Org | News | Comments

WHITE PLAINS, N.Y. and WAYNE, N.J., March 15, 2011 /- Vanessa Minnillo is making it a priority to share an important public health message with women nationwide. Minnillo is working with March of Dimes® and Bayer HealthCare Pharmaceuticals to help educate all women of reproductive...

OVA1 Included in Latest ACOG/SGO Committee Opinion

March 14, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, March 14, 2011 /- (Nasdaq: VRML ) –Vermillion, a molecular diagnostics company, announced today the inclusion of OVA1® as part of the recently published ACOG/SGO committee opinion. In the March edition of Obstetrics and Gynecology , the American College of...

K-V Pharmaceutical Company Announces Comprehensive Patient Assistance Program for Makenaâ„¢

March 8, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, March 8, 2011 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company"), a specialty pharmaceutical company, along with its branded subsidiary, Ther-Rx Corporation, today announced the details of its patient assistance program for Makena ™ -eligible patients....

FDA Approves Makenaâ„¢, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm ...

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Feb. 4, 2011 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company"), a specialty pharmaceutical company, announced today that it has been informed by Hologic, Inc. that the U.S. Food and Drug Administration (FDA) granted approval for Makena™ (hydroxyprogesterone...

FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Feb. 4, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one...

FDA Approves Hologic's Makenaâ„¢ (Formerly Referred to as Gestivaâ„¢) Pharmaceutical

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., Feb. 4, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading